Eagle Health Investments LP - Q4 2021 holdings

$410 Million is the total value of Eagle Health Investments LP's 28 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 11.1% .

 Value Shares↓ Weighting
HUM BuyHUMANA INC$36,469,000
+36.8%
78,621
+14.7%
8.88%
+5.1%
AZN BuyASTRAZENECA PLCsponsored adr$35,629,000
+32.0%
611,665
+36.1%
8.68%
+1.4%
UTHR BuyUNITED THERAPEUTICS CORP DEL$33,155,000
+83.2%
153,438
+56.5%
8.08%
+40.8%
IQV BuyIQVIA HLDGS INC$28,095,000
+44.5%
99,577
+22.7%
6.84%
+11.0%
ARGX BuyARGENX SEsponsored adr$21,828,000
+34.8%
62,332
+16.2%
5.32%
+3.5%
ADPT BuyADAPTIVE BIOTECHNOLOGIES COR$21,066,000
+40.4%
750,760
+70.1%
5.13%
+7.8%
BPMC BuyBLUEPRINT MEDICINES CORP$20,634,000
+13.9%
192,639
+9.3%
5.03%
-12.5%
NTRA BuyNATERA INC$19,770,000
+7.9%
211,694
+28.7%
4.82%
-17.1%
ALNY BuyALNYLAM PHARMACEUTICALS INC$19,282,000
+13.3%
113,702
+26.2%
4.70%
-12.9%
VRTX BuyVERTEX PHARMACEUTICALS INC$18,039,000
+236.6%
82,144
+178.0%
4.40%
+158.5%
INSP BuyINSPIRE MED SYS INC$17,543,000
+9.7%
76,253
+11.1%
4.27%
-15.7%
CANO BuyCANO HEALTH INC$17,355,000
+102.3%
1,947,779
+188.0%
4.23%
+55.4%
OM SellOUTSET MED INC$15,164,000
-7.8%
329,000
-1.1%
3.70%
-29.2%
AXNX BuyAXONICS INC$14,362,000
+15.9%
256,465
+34.7%
3.50%
-11.0%
DXCM SellDEXCOM INC$14,337,000
-11.1%
26,700
-9.5%
3.49%
-31.7%
AGIO BuyAGIOS PHARMACEUTICALS INC$14,181,000
+30.5%
431,413
+83.2%
3.46%
+0.2%
AMWL BuyAMERICAN WELL CORPcl a$13,577,000
+65.4%
2,247,908
+149.4%
3.31%
+27.0%
SGEN NewSEAGEN INC$12,445,00080,500
+100.0%
3.03%
GH BuyGUARDANT HEALTH INC$11,938,000
-0.2%
119,360
+24.8%
2.91%
-23.3%
MRTX  MIRATI THERAPEUTICS INC$7,628,000
-17.1%
52,0000.0%1.86%
-36.3%
CMAX BuyCAREMAX INC$5,489,000
-7.9%
714,755
+15.9%
1.34%
-29.3%
FDMT Buy4D MOLECULAR THERAPEUTICS IN$2,898,000
+88.2%
132,090
+131.4%
0.71%
+44.7%
KYMR  KYMERA THERAPEUTICS INC$2,349,000
+8.1%
37,0000.0%0.57%
-17.0%
BEAM NewBEAM THERAPEUTICS INC$2,303,00028,900
+100.0%
0.56%
ARVN  ARVINAS INC$1,889,000
-0.1%
23,0000.0%0.46%
-23.2%
CCCC  C4 THERAPEUTICS INC$1,520,000
-27.9%
47,2000.0%0.37%
-44.7%
LYEL  LYELL IMMUNOPHARMA INC$774,000
-47.7%
100,0000.0%0.19%
-59.7%
OLK  OLINK HLDG ABsponsored ads$728,000
-24.9%
40,0000.0%0.18%
-42.5%
DRNA ExitDICERNA PHARMACEUTICALS INC$0-406,525
-100.0%
-2.60%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IQVIA HLDGS INC12Q3 20239.6%
UNITED THERAPEUTICS CORP DEL12Q3 20238.7%
ALNYLAM PHARMACEUTICALS INC12Q3 20238.5%
NATERA INC12Q3 20238.5%
ARGENX SE12Q3 20237.0%
DEXCOM INC12Q3 20235.7%
OUTSET MED INC12Q3 20237.3%
AGIOS PHARMACEUTICALS INC12Q3 20237.2%
ADAPTIVE BIOTECHNOLOGIES COR12Q3 20235.1%
GUARDANT HEALTH INC12Q3 20233.8%

View Eagle Health Investments LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-10-27
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-10-20

View Eagle Health Investments LP's complete filings history.

Compare quarters

Export Eagle Health Investments LP's holdings